TGF-β1 inhibitors increasing the radiosensitivity of H460 lung cancer cells

Qianyi HUANG,Yifan ZHAO,Youqin JIANG,Jingdong WANG,Hongying YANG
DOI: https://doi.org/10.11889/j.1000-3436.2016.rrj.34.010202
2016-01-01
Journal of Radiation Research and Radiation Processing
Abstract:The purpose of this study was to investigate the radiosensitizing effect of SB431542, a selective inhibitor of TGF-β1 receptor, on H460 non-small-cell lung cancer cells and relative interfering effect on DNA damage response (DDR). Clonogenic assay was used to measure the radiosensitizing effects of SB431542 on H460 cells; xenograft mouse model was used to study the radiosensitizationin vivo; flow cytometry was used to determine cell cycle distribution and apoptosis; immunofluorescence microscopy was used to assess 53BP1 foci and pospho-DNA-PKcs foci. The results showed that SB431542 could increase the radiosensitivity of H460 cells. Pretreatment of H460 cells with SB431542 prior to irradiation initiated fast DDR but inhibited DNA repairvia non-homologous end joining pathway and thus resulting in more unrepaired DNA double strand breaks, which caused more severe cell cycle delay. However, apoptosis did not contribute to the radiosensitization. The data from xenograft model showed that compared with irradiation alone, the combination of SB431542 and 5 Gy of X-rays on three consecutive days significantly delayed the tumor growth from 5~12 d post treatment. All the above indicate that inhibition of TGF-β1 pathway using SB431542 prior to irradiation can attenuate DNA damage repair and disturb cell cycle distribution, leading to decreased clonogenic cell survival and tumor growth delay, which can be an effective adjunct in radiotherapy for certain lung cancer subtypes.
What problem does this paper attempt to address?